Peregrine reports new study from Duke shows anti-HIV potential of targeting PS on cells
Monday, April 5, 2010 - 09:49
in Health & Medicine
Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today announced the publication of data showing phosphatidylserine (PS)-targeting antibodies can block one of the key ways the AIDS virus gains entry...